Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy in Gastrointestinal Subepithelial Tumors

Gyu Young Pih; Do Hoon Kim

doi:10.5946/ce.2019.100

Articles

Page Path: HOME > Clin Endosc > Volume 52(4); 2019 > Article

Focused Review Series: Recent Update of Endoscopic Ultrasonography in Gastrointestinal Subepithelial Tumors Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy in Gastrointestinal Subepithelial Tumors: Gyu Young Pih, Do Hoon Kim; Clinical Endoscopy 2019;52(4):314-320.
DOI: https://doi.org/10.5946/ce.2019.100
Published online: July 30, 2019

Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Correspondence: Do Hoon Kim Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-3193, Fax: +82-2-476-0824, E-mail: dohoon.md@gmail.com

• Received: May 15, 2019 • Revised: June 24, 2019 • Accepted: June 25, 2019

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

8,052 Views
194 Download
20 Web of Science
26 Crossref
23 Scopus

prev next

Full Article

Download PDF

Abstract
INTRODUCTION
INDICATION
DIAGNOSTIC YIELD
CONCLUSIONS
NOTES
REFERENCES

Abstract

The incidence of asymptomatic and incidentally found upper gastrointestinal subepithelial tumors (SETs) is increasing with the implementation of national cancer screening and the development of high-resolution endoscopy in Korea. However, endoscopy alone cannot be used to determine whether SETs are benign or malignant. Endoscopic ultrasound (EUS) is used to further characterize these lesions through the examination of their layered structure, internal echogenicity, size, and relationship to the extramural structure. These provide additional information on whether the lesion is benign or malignant. Nevertheless, the sensitivity and specificity of EUS alone in predicting malignancy is unsatisfactory. Recent guidelines have recommended deciding the timing of EUS-fine needle aspiration and biopsy (EUS-FNA/B) for SETs based on tumor size, malignant features on endoscopy, and high-risk features on EUS. The diagnostic accuracy of EUS-FNA/B is reportedly influenced by factors including needle size, number of needle passes, use of suction, use of a stylet in the needle assembly, fanning technique, availability of an on-site cytopathologist, and experience of the endosonographer. Therefore, according to the characteristics of the SETs, various subsequent methods and techniques should be appropriately employed to improve the diagnostic yield of EUS-FNA/B.
Keywords: Endoscopic ultrasound; Subepithelial tumor; Stomach

INTRODUCTION

Currently, incidental findings of gastrointestinal (GI) subepithelial tumors (SETs) are increasing because of the implementation of national cancer screening endoscopy and the development of high-resolution endoscopy in Korea. The prevalence of gastric SETs reportedly ranges from 0.36% to 1.7% [1,2]. A decision is required at the time of discovery on whether the tumor should be further evaluated or if it can be observed with periodic follow-up. Indefinite decisions for SETs can result in poor cost-effectiveness with unnecessary endoscopy and emotional distress in patients, leading to poor compliance. Although endoscopic ultrasound (EUS), computed tomography (CT), and bite-on-bite biopsy may help in accurate diagnosis, these methods cannot always be performed for all SETs.

EUS is used to further characterize lesions through the examination of their layered structure, internal echogenicity, size, and relationship to the extramural structure. These provide additional information on whether the lesion is benign or malignant. However, although there are lesions with typical EUS findings, such as lipomas, duplication cysts, and heterotopic pancreas [3], hypoechoic lesions originating from the fourth layer, such as leiomyomas, gastrointestinal stromal tumors (GISTs), and schwannomas, are difficult to distinguish with EUS alone. A previous study reported that the sensitivity and specificity of EUS in predicting malignancy was 64% and 80%, respectively [4]. Furthermore, the interpretation of the EUS image is dependent on the operator. Therefore, tissue acquisition through EUS-guided fine needle aspiration and biopsy (EUS-FNA/B) is needed for further differential diagnosis. EUS-FNA/B has the advantage of having the capability of visualizing the subepithelial layer, as well as reaching adjacent organs located in a difficult area to be aspirated by the previous endoscopic tissue acquisition modalities. In addition to its minimal invasiveness, EUS-FNA/B is preferred over CT-guided biopsy because it does not induce radiation and enables real-time visualization of the needle tip. However, it has limitations in aspect of difficulty in visualizing the needle tip clearly and consistently and interference of the image by bowel gas. We reviewed the indications for EUS-FNA/B in gastric SETs and the methods that can be used to increase the diagnostic yield.

INDICATION

The basic principle of EUS-FNA/B is to obtain information that can affect the patients’ treatment. EUS-FNA/B should be performed when the choice of treatment can be changed depending on the tissue diagnosis. If surgery is planned, the findings of EUS-FNA/B can change the selected surgical procedure. Clinically important SETs, such as leiomyomas, GISTs, schwannomas, heterotopic pancreas, SET-like carcinomas, and metastatic tumors can have a hypoechoic echo pattern and similar endoscopic features. For the accurate diagnosis of these tumors, it is important to obtain a sufficient amount of tissue so that the structure of the lesion can be sufficiently assessed and to enable immunohistochemical examination. Recent guidelines have recommended deciding the timing of tissue sampling based on the size of the tumor and high-risk features for malignancy on endoscopy and EUS (Table 1).

Tumor size

Current guidelines have suggested 2 cm as the cutoff diameter of SETs for further evaluation or periodic surveillance, despite the previously recommended cutoff of 3 cm by the American Gastroenterological Association [5-7]. The European Society of Medical Oncology (ESMO) and the European Society of Gastrointestinal Endoscopy (ESGE) recommended EUS for SETs less than 2 cm in the esophagus, stomach, and duodenum followed by periodic surveillance [8,9]. According to previous reports on the natural clinical course of small SETs, less than 2–3 cm in size, during 24–48 months of follow-up, there was no tumor-related death or a newly developed symptom related to disease progression, with only less than 8.5% of interval change in the tumor size [10,11]. Another study reported that GISTs less than 2 cm do not metastasize if the number of mitoses is less than 5/50 high-power fields (HPFs). In addition, despite the high rate of metastases of GISTs with a mitotic count exceeding 5/50 HPFs in the GI tract, small gastric GISTs showed exceptional results without increased metastases rates [12]. As asymptomatic SETs less than 2 cm harbor a very low risk of progression and usually show a benign clinical course, these tumors can be followed up periodically at intervals of 6 months–2 years [13,14]. However, SETs showing growth in size during the follow-up period should be further evaluated with tissue sampling for pathologic diagnosis, regardless of the size.

High-risk features on endoscopy and EUS

Gastric SETs, particularly mesenchymal tumors, such as GISTs, leiomyomas, or schwannomas, show similar findings on endoscopy and EUS. Therefore, efforts have been made to determine specific risk features that distinguish these tumors. Gastric SETs with high-risk features on endoscopy and EUS may have a clinically malignant potential. Biopsy or resection of these tumors is required to determine the long-term prognosis.

Large size (≥2 cm), ulceration, irregular surface, and growth during the follow-up are significant features indicating potentially malignant GISTs [7,15-17]. As gastric neuroendocrine tumors and gastric carcinomas resembling submucosal tumors (by virtue of occurring in the submucosa) often present with a mucosal ulceration or an irregular margin, SETs with an ulceration or a depressed surface are recommended for biopsy to obtain a definite diagnosis [7]. Current guidelines suggest further evaluation, including CT scan, EUS, or EUS-FNA/B for SETs with malignant features on endoscopy [5-7].

The Japan Gastroenterological Endoscopy Society has identified high-risk lesions on EUS as those having an irregular border, internal heterogeneity, such as anechoic areas and echogenic foci, heterogeneous enhancement, and regional lymph node enlargement [15,18]. The well-known EUS findings that generally cause suspicion of malignancy include (1) a tumor size greater than 4 cm, (2) echogenic foci greater than 3 mm, (3) cystic spaces greater than 4 mm, (4) an irregular border, and (5) adjacent lymph node with malignant pattern (Fig. 1) [18-23]. The presence of at least two of the criteria from (1) to (4) predicts a malignant GIST with 80%–100% sensitivity [19], whereas the combined presence of two of the criteria from (3) to (5) has a positive predictive value of 100% for a malignant or borderline gastrointestinal stromal cell tumor [18]. The optimal size for predicting malignant GISTs was reported to be 35 mm, with a sensitivity and specificity of 92.3% and 78.8%, respectively [24]. The combinations of these several features enable narrowing down the possible diagnosis and allow identifying malignant lesions.

DIAGNOSTIC YIELD

Although EUS-FNA/B has the strength of having high sensitivity and high specificity, its sampling adequacy and diagnostic rates were reported to be only 74.5%–83.0% and 71.0%–83.9%, respectively [25-28]. The diagnostic accuracy of EUS-FNA/B is influenced by many factors, including the nature of the target lesion, degree of technical difficulty of the procedure, size of the needle, number of needle passes, use of suction, use of a stylet in the needle assembly, special maneuvers to procure better-quality tissue, such as the fanning technique, availability of an on-site cytopathologist, and experience of the endosonographer (Table 2).

Nature of the target lesion and patient

Transesophageal and transgastric EUS-FNA/B with a straight scope position result in a higher diagnostic yield than does transduodenal EUS-FNA/B with an angulated scopetip position [29]. The diagnostic yield is also influenced by the patient’s age and the location of the tumor. A patient age of under 60 years and a lower third location of an SET are predictive factors of an inadequate tissue yield in EUS-FNA/B [27]. When the tumor size was divided into 2-cm intervals of 0–2, 2–4, and ≥4 cm, the diagnostic rates were 71%, 86%, and 100%, respectively [28].

FNA needle

Needle choice is based on the consideration of the following: the ability to acquire adequate cellular material for accurate diagnosis, flexibility to approach the tumor, and minimal complications. Currently, needles for EUS-FNA are available in 4 sizes, including 19, 20, 22, and 25 gauge (Table 3). A 19-gauge needle with its larger bore is considered to acquire larger tissue samples and to provide better cellularity than that of fine needles [30]. However, because of the possibility of blood dilution of the specimen and reduced maneuverability in areas with sharp angulation, a large-bore needle does not necessarily lead to favorable outcomes with a higher diagnostic yield [31,32]. Therefore, for tumors located in the fundus or antrum, a 22-gauge needle is often preferred because of its maneuverability in angulated areas. In addition, lesion types such as GISTs and lymphomas may need a large-bore needle because their diagnosis requires specimens with preserved tissue architecture [33,34]. Meanwhile, a recent meta-analysis and systemic review showed no significant difference in the accuracy and complication rates between the 22-gauge needle and the 25-gauge needle, with the 25-gauge needle only showing a small advantage in acquiring an adequate sample [35,36]. Recently, a new generation of flexible 19-gauge core biopsy needles has been introduced, which has shown promising results for lesions requiring a transduodenal approach [37]. A Korean EUS study group compared a 22-gauge aspiration needle with a 22-gauge biopsy needle for sampling SETs, and reported that the EUS-FNB group had significantly higher yields of histological core samples and higher diagnostic sufficiency rates [38]. In addition, EUS-FNB with a 20-gauge ProCore needle is a technically feasible and effective modality for histopathologic diagnosis of gastrointestinal SETs, providing adequate core samples with fewer needle passes [39].

Number of needle passes

The number of needle passes required to achieve the highest diagnostic yield vary widely. The presence of an on-site cytopathologist is the main factor influencing the number of needle passes, in addition to the characteristics of the lesion (cystic or solid) and its location [40]. In multivariate analyses, although the number of needle passes was not found to be a significant factor for the adequacy of collected specimens [25,26], gastric SETs have shown an 83% sample adequacy with 2.5 needle passes, a diagnostic accuracy of 83.9% with 5.3 needle passes, and the plateau of diagnostic accuracy was reached with 2.5–4 needle passes [25,26,41].

Use of suction

The role of suction during EUS-FNA is still controversial. However, depending on the nature of the target lesion, the effect of suction utilization may be different. In vascular-rich lesions, such as lymph nodes, suction may result in blood dilution, thus yielding poor-quality samples. A randomized controlled study reported that the use of suction resulted in better cellularity, more blood in specimens, and no improvement in diagnostic yield [42]. On the contrary, in fibrotic lesions or solid masses, suction may enable acquiring adequate samples [43-45]. In several studies, cellularity, accuracy, and sensitivity were higher in the suction group than in the non-suction group [46,47]. However, in another randomized controlled study, suction did not improve the diagnostic yield of FNA [47]. A previous study on the suction method recommended the use of suction in lesions suspected to be mesenchymal tumors, considering the reported cohesiveness of mesenchymal tissue [48].

Stylet

The use of a stylet has been proposed to optimize the diagnostic yield of tissue acquisition in solid lesions. This method prevents the needle tip from being contaminated or blocked by a plug of gastric wall tissue before reaching the target lesion, thereby increasing the ability of tissue aspiration and improving the quality of the specimen. However, randomized trials have demonstrated that the use of a stylet during EUSFNA does not improve the diagnostic yield and cellularity [49-51]. The use of a stylet is not recommended considering the labor used to reinsert the stylet and the prolongation of the procedure time. In addition, insertion and retrieval of the stylet may be difficult in angulated areas because of the bending of the endoscope. Furthermore, re-use of the stylet during the second and third tissue acquisitions increases the risk of needle stick injury. However, most investigators use a stylet during puncture for removing the aspirated sample from the slide.

Fanning

Fanning is a technique for acquiring specimens from multiple areas through a single puncture, in which the needle is moved back and forth in a fan shape by using the elevator and the up/down dial control of the endoscope. The fanning method has been used to improve the diagnostic yield, particularly in cancerous tumors with a necrotic center. In a study on pancreatic masses, fanning resulted in fewer numbers of passes needed to obtain a diagnosis, with a high first-pass diagnostic rate [52]. Although SET is often not a cancerous lesion having a necrotic portion and may be firm when located in the muscular layer, the fanning technique is still expected to increase the diagnostic rate by collecting tissue from multiple sites of the tumor.

On-site cytopathologist

The presence of an on-site cytopathologist is considered to be a key factor for the diagnostic sensitivity in EUS-FNA [53], as it improves the diagnostic yield, increases the adequacy of samples, and reduces the number of needle passes [54-59]. Previous studies have reported that the presence of an on-site cytopathologist increased the rates of sample adequacy by 10%–29%, resulting in a 10%–15% increase in the diagnostic rate [45,60,61]. However, many hospitals do not have an available on-site cytopathologist. In a recent study conducted to overcome these limitations, gross evaluation of the adequacy of samples, such as macroscopic on-site quality evaluation (MOSE) or rapid on-site evaluation (ROSE), by an EUS examiner resulted in improvements in the diagnostic accuracy of EUS-FNA [62-65]. By using MOSE, when the presence of a macroscopic visible core of more than 4 mm was considered to indicate an appropriate specimen, the macroscopic evaluation failed in only 7% of cytology samples and in 13.5% of histology samples [63]. According to the ROSE study, endosonographers who underwent extensive training in processing techniques with a pathologist tended to need fewer needle passes than those who performed FNA without ROSE. According to these reports, gross evaluation of the adequacy of samples by endosonographers may be sufficient in deciding the number of needle passes when no cytopathologists are available.

CONCLUSIONS

EUS-FNA/B is a minimally invasive and effective diagnostic method that plays an important role in the diagnosis of gastrointestinal SETs, which, in turn, have a decisive impact on making appropriate treatment choices. Although the tumor size that requires EUS-FNA/B has not been established, current guidelines have suggested that tumors >2 cm and having malignant features, such as ulceration and an irregular border, require a pathologic diagnosis through EUS-FNA/B. Recently, new-generation flexible needles with improved diagnostic yield have been introduced. According to the characteristics of the SETs, a suitable FNA/B needle should be used and various methods such as the use of a stylet, the suction method, and the fanning technique should be appropriately employed to improve the diagnostic yield of EUS-FNA.

Conflicts of Interest:The authors have no financial conflicts of interest.

Fig. 1.

Endoscopic ultrasound features suggestive of a malignant gastric subepithelial tumor.

Table 1.

Features of Gastric Subepithelial Tumor Requiring Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy

Malignant features on endoscopy

Large size (≥2 cm)

Ulceration

Irregular surface

Growth during follow-up

Malignant features on EUS

Echogenic foci >3 mm

Cystic spaces >4 mm

Irregular border

Adjacent lymph node

EUS, endoscopic ultrasound.

Table 2.

Studies on Factors Influencing Result of Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy

Variable	Study	Location (n)	Results
Needle size	Hoda et al. [25]	Stomach (112)	Diagnostic yield: 22 g = 62% diagnostic, 22% suspicious
	Mekky et al. [26]	Stomach (141)	Diagnostic yield: 22 g = 43% diagnostic, 39% suspicious
	Suzuki et al. [27]	Stomach (47)	Diagnostic yield: 22 g = 74.5%
	Larghi et al. [30]	Stomach (96), esophagus, (13) duodenum (10), rectum (2)	Adequate sample: 19 g = 93.4%
	Eckardt et al. [31]	Stomach (46)	Diagnostic yield: 19 g = 52%
	Watson et al. [32]	Stomach (55), esophagus (7), duodenum (4)	Diagnostic yield: 22 g = 64%, 19 g = 79% (p=0.345)
	Imazu et al. [36]	Stomach (20)	Accuracy: 25 g = 60%, 22 g = 80% (p=not significant)
Needle pass	Hoda et al. [25]	Stomach (70), esophagus (34), duodeum (8)	Diagnostic yield: mean needle pass 5.3 = 83.9%
Needle pass	Kim et al. [39]	Stomach (30), esophagus (4), duodenum (2)	Adequate sample: pass 2 = 80.6%, Pass 3 = 79.4%
ROSE	Tamura et al. [64]	Stomach (25), duodenum (6), rectum (1)	Diagnostic accuracy: rose = 100%, no rose = 80% (p=0.03)

ROSE, rapid on-site evaluation.

Table 3.

Endoscopic Ultrasound-Guided Fine Needle Aspiration Needles

Manufacturer/Model	Needle diameter (G)	Intended sample
Boston Scientific, USA
Expect^TM	25, 22, 19 G^a)	Aspirated cells
Expect^TM 19 Flex	19 G Flex	Aspirated cells
Acquire^TM	25, 22 G	Core biopsy
Cook Medical, Ireland & USA
EchoTip^® Ultra	25, 22, 19 G	Aspirated cells
EchoTip^® ProCore^TM	25, 22, 20, 19 G	Core biopsy
Finemedix, Korea
ClearTip^® (A type)	25, 22, 19 G	Aspirated cells
ClearTip^® (B type)	25, 22, 19 G	Core biopsy
Medi-Globe, Germany
SonoTip^® Pro Control	25, 22, 19 G	Aspirated cells
Olympus, Japan^b)
EZ-shot 3 plus	22, 19 G	Aspirated cells + Core biopsy

^a)19 G needle have been used to acquire core biopys samples;

^b)Compatible only with Olympus scopes.

REFERENCES

1. Hedenbro JL, Ekelund M, Wetterberg P. Endoscopic diagnosis of submucosal gastric lesions. The results after routine endoscopy. Surg Endosc 1991;5:20–23.Article PubMed PDF
2. Lee JH, Lee HL, Ahn YW, et al. Prevalence of gastric subepithelial tumors in Korea: a single center experience. Korean J Gastroenterol 2015;66:274–276.Article PubMed
3. Landi B, Palazzo L. The role of endosonography in submucosal tumours. Best Pract Res Clin Gastroenterol 2009;23:679–701.Article PubMed
4. Ji JS, Lee BI, Choi KY, et al. Diagnostic yield of tissue sampling using a bite-on-bite technique for incidental subepithelial lesions. Korean J Intern Med 2009;24:101–105.Article PubMed PMC PDF
5. Cho JW. Current guidelines in the management of upper gastrointestinal subepithelial tumors. Clin Endosc 2016;49:235–240.Article PubMed PMC PDF
6. Nishida T, Blay JY, Hirota S, Kitagawa Y, Kang YK. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer 2016;19:3–14.Article PubMed PMC PDF
7. Nishida T, Hirota S, Yanagisawa A, et al. Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version. Int J Clin Oncol 2008;13:416–430.Article PubMed PDF
8. Casali PG, Abecassis N, Bauer S, et al. Gastrointestinal stromal tumours: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018;29(Suppl 4):iv68–iv78.Article PubMed PDF
9. Dumonceau JM, Deprez PH, Jenssen C, et al. Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline - updated January 2017. Endoscopy 2017;49:695–714.Article PubMed PDF
10. Kim MY, Jung HY, Choi KD, et al. Natural history of asymptomatic small gastric subepithelial tumors. J Clin Gastroenterol 2011;45:330–336.Article PubMed
11. Yegin EG, Kani T, Banzragch M, Kalayci C, Bicakci E, Duman DG. Survival in patients with hypoechoic muscularis propria lesions suggestive of gastrointestinal stromal tumors in gastric wall. Acta Gastroenterol Belg 2015;78:12–17.PubMed
12. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006;23:70–83.Article PubMed
13. Agaimy A, Wünsch PH, Hofstaedter F, et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol 2007;31:113–120.Article PubMed
14. Kawanowa K, Sakuma Y, Sakurai S, et al. High incidence of microscopic gastrointestinal stromal tumors in the stomach. Hum Pathol 2006;37:1527–1535.Article PubMed
15. Nishida T, Kawai N, Yamaguchi S, Nishida Y. Submucosal tumors: comprehensive guide for the diagnosis and therapy of gastrointestinal submucosal tumors. Dig Endosc 2013;25:479–489.Article PubMed
16. Demetri GD, von Mehren M, Antonescu CR, et al. NCCN task force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw 2010;8 Suppl 2:S1–S41; quiz S42-S44.Article PubMed
17. Yegin EG, Duman DG. Small EUS-suspected gastrointestinal stromal tumors of the stomach: an overview for the current state of management. Endosc Ultrasound 2016;5:69–77.Article PubMed PMC
18. Palazzo L, Landi B, Cellier C, Cuillerier E, Roseau G, Barbier JP. Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours. Gut 2000;46:88–92.Article PubMed PMC
19. Chak A, Canto MI, Rösch T, et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc 1997;45:468–473.Article PubMed
20. Brand B, Oesterhelweg L, Binmoeller KF, et al. Impact of endoscopic ultrasound for evaluation of submucosal lesions in gastrointestinal tract. Dig Liver Dis 2002;34:290–297.Article PubMed
21. Rösch T, Kapfer B, Will U, et al. Accuracy of endoscopic ultrasonography in upper gastrointestinal submucosal lesions: a prospective multicenter study. Scand J Gastroenterol 2002;37:856–862.Article PubMed
22. Ando N, Goto H, Niwa Y, et al. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc 2002;55:37–43.Article PubMed
23. Okubo K, Yamao K, Nakamura T, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of gastrointestinal stromal tumors in the stomach. J Gastroenterol 2004;39:747–753.Article PubMed PDF
24. Kim GH, Park DY, Kim S, et al. Is it possible to differentiate gastric GISTs from gastric leiomyomas by EUS? World J Gastroenterol 2009;15:3376–3381.Article PubMed PMC
25. Hoda KM, Rodriguez SA, Faigel DO. EUS-guided sampling of suspected GI stromal tumors. Gastrointest Endosc 2009;69:1218–1223.Article PubMed
26. Mekky MA, Yamao K, Sawaki A, et al. Diagnostic utility of EUS-guided FNA in patients with gastric submucosal tumors. Gastrointest Endosc 2010;71:913–919.Article PubMed
27. Suzuki T, Arai M, Matsumura T, et al. Factors associated with inadequate tissue yield in EUS-FNA for gastric SMT. ISRN Gastroenterol 2011;2011:619128.Article PubMed PMC PDF
28. Akahoshi K, Sumida Y, Matsui N, et al. Preoperative diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration. World J Gastroenterol 2007;13:2077–2082.Article PubMed PMC
29. Haseeb A, Taylor LJ, Adler DG. Comparing endoscopic ultrasoundguided core biopsies of solid pancreatic and extrapancreatic lesions: a large single-operator experience with a new fine-needle biopsy needle. Ann Gastroenterol 2018;31:742–746.Article PubMed PMC
30. Larghi A, Fuccio L, Chiarello G, et al. Fine-needle tissue acquisition from subepithelial lesions using a forward-viewing linear echoendoscope. Endoscopy 2014;46:39–45.Article PubMed PDF
31. Eckardt AJ, Adler A, Gomes EM, et al. Endosonographic large-bore biopsy of gastric subepithelial tumors: a prospective multicenter study. Eur J Gastroenterol Hepatol 2012;24:1135–1144.Article PubMed
32. Watson RR, Binmoeller KF, Hamerski CM, et al. Yield and performance characteristics of endoscopic ultrasound-guided fine needle aspiration for diagnosing upper GI tract stromal tumors. Dig Dis Sci 2011;56:1757–1762.Article PubMed PDF
33. DeWitt J, Emerson RE, Sherman S, et al. Endoscopic ultrasound-guided Trucut biopsy of gastrointestinal mesenchymal tumor. Surg Endosc 2011;25:2192–2202.Article PubMed PDF
34. Amador-Ortiz C, Chen L, Hassan A, et al. Combined core needle biopsy and fine-needle aspiration with ancillary studies correlate highly with traditional techniques in the diagnosis of nodal-based lymphoma. Am J Clin Pathol 2011;135:516–524.Article PubMed PDF
35. Affolter KE, Schmidt RL, Matynia AP, Adler DG, Factor RE. Needle size has only a limited effect on outcomes in EUS-guided fine needle aspiration: a systematic review and meta-analysis. Dig Dis Sci 2013;58:1026–1034.Article PubMed PDF
36. Imazu H, Uchiyama Y, Kakutani H, et al. A prospective comparison of EUS-guided FNA using 25-gauge and 22-gauge needles. Gastroenterol Res Pract 2009;2009:546390.Article PubMed PMC PDF
37. Varadarajulu S, Bang JY, Hebert-Magee S. Assessment of the technical performance of the flexible 19-gauge EUS-FNA needle. Gastrointest Endosc 2012;76:336–343.Article PubMed
38. Kim GH, Cho YK, Kim EY, et al. Comparison of 22-gauge aspiration needle with 22-gauge biopsy needle in endoscopic ultrasonography-guided subepithelial tumor sampling. Scand J Gastroenterol 2014;49:347–354.Article PubMed
39. Kim DH, Kim GH, Cho CM, et al. Feasibility of a 20-gauge ProCore needle in EUS-guided subepithelial tumor sampling: a prospective multicenter study. BMC Gastroenterol 2018;18:151.Article PubMed PMC PDF
40. Petrone MC, Arcidiacono PG. Basic technique in endoscopic ultrasound-guided fine needle aspiration for solid lesions: how many passes? Endosc Ultrasound 2014;3:22–27.Article PubMed PMC
41. Pellisé Urquiza M, Fernández-Esparrach G, Solé M, et al. Endoscopic ultrasound-guided fine needle aspiration: predictive factors of accurate diagnosis and cost-minimization analysis of on-site pathologist. Gastroenterol Hepatol 2007;30:319–324.Article PubMed
42. Wallace MB, Kennedy T, Durkalski V, et al. Randomized controlled trial of EUS-guided fine needle aspiration techniques for the detection of malignant lymphadenopathy. Gastrointest Endosc 2001;54:441–447.Article PubMed
43. Santos JE, Leiman G. Nonaspiration fine needle cytology. Application of a new technique to nodular thyroid disease. Acta Cytol 1988;32:353–356.PubMed
44. Kinney TB, Lee MJ, Filomena CA, et al. Fine-needle biopsy: prospective comparison of aspiration versus nonaspiration techniques in the abdomen. Radiology 1993;186:549–552.Article PubMed
45. Polkowski M, Larghi A, Weynand B, et al. Learning, techniques, and complications of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) technical guideline. Endoscopy 2012;44:190–206.Article PubMed PDF
46. Lee JK, Choi JH, Lee KH, et al. A prospective, comparative trial to optimize sampling techniques in EUS-guided FNA of solid pancreatic masses. Gastrointest Endosc 2013;77:745–751.Article PubMed
47. Puri R, Vilmann P, Săftoiu A, et al. Randomized controlled trial of endoscopic ultrasound-guided fine-needle sampling with or without suction for better cytological diagnosis. Scand J Gastroenterol 2009;44:499–504.Article PubMed
48. Eckardt AJ, Jenssen C. Current endoscopic ultrasound-guided approach to incidental subepithelial lesions: optimal or optional? Ann Gastroenterol 2015;28:160–172.PubMed PMC
49. Sahai AV, Paquin SC, Gariépy G. A prospective comparison of endoscopic ultrasound-guided fine needle aspiration results obtained in the same lesion, with and without the needle stylet. Endoscopy 2010;42:900–903.Article PubMed
50. Rastogi A, Wani S, Gupta N, et al. A prospective, single-blind, randomized, controlled trial of EUS-guided FNA with and without a stylet. Gastrointest Endosc 2011;74:58–64.Article PubMed
51. Wani S, Gupta N, Gaddam S, et al. A comparative study of endoscopic ultrasound guided fine needle aspiration with and without a stylet. Dig Dis Sci 2011;56:2409–2414.Article PubMed PDF
52. Bang JY, Magee SH, Ramesh J, Trevino JM, Varadarajulu S. Randomized trial comparing fanning with standard technique for endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic mass lesions. Endoscopy 2013;45:445–450.Article PubMed PMC PDF
53. Varadarajulu S, Fockens P, Hawes RH. Best practices in endoscopic ultrasound-guided fine-needle aspiration. Clin Gastroenterol Hepatol 2012;10:697–703.Article PubMed
54. Collins BT, Murad FM, Wang JF, Bernadt CT. Rapid on-site evaluation for endoscopic ultrasound-guided fine-needle biopsy of the pancreas decreases the incidence of repeat biopsy procedures. Cancer Cytopathol 2013;121:518–524.Article PubMed
55. Schmidt RL, Witt BL, Matynia AP, Barraza G, Layfield LJ, Adler DG. Rapid on-site evaluation increases endoscopic ultrasound-guided fine-needle aspiration adequacy for pancreatic lesions. Dig Dis Sci 2013;58:872–882.Article PubMed PDF
56. Klapman JB, Logrono R, Dye CE, Waxman I. Clinical impact of onsite cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol 2003;98:1289–1294.Article PubMed
57. Jhala NC, Jhala DN, Chhieng DC, Eloubeidi MA, Eltoum IA. Endoscopic ultrasound-guided fine-needle aspiration. A cytopathologist’s perspective. Am J Clin Pathol 2003;120:351–367.Article PubMed PDF
58. Iglesias-Garcia J, Dominguez-Munoz JE, Abdulkader I, et al. Influence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses. Am J Gastroenterol 2011;106:1705–1710.Article PubMed PDF
59. Alsohaibani F, Girgis S, Sandha GS. Does onsite cytotechnology evaluation improve the accuracy of endoscopic ultrasound-guided fine-needle aspiration biopsy? Can J Gastroenterol 2009;23:26–30.Article PubMed PMC PDF
60. Storch I, Jorda M, Thurer R, et al. Advantage of EUS Trucut biopsy combined with fine-needle aspiration without immediate on-site cytopathologic examination. Gastrointest Endosc 2006;64:505–511.Article PubMed
61. Turhan N, Aydog G, Ozin Y, Cicek B, Kurt M, Oguz D. Endoscopic ultrasonography-guided fine-needle aspiration for diagnosing upper gastrointestinal submucosal lesions: a prospective study of 50 cases. Diagn Cytopathol 2011;39:808–817.Article PubMed
62. Iwashita T, Yasuda I, Mukai T, et al. Macroscopic on-site quality evaluation of biopsy specimens to improve the diagnostic accuracy during EUS-guided FNA using a 19-gauge needle for solid lesions: a single-center prospective pilot study (MOSE study). Gastrointest Endosc 2015;81:177–185.Article PubMed
63. Moller K, Papanikolaou IS, Toermer T, et al. EUS-guided FNA of solid pancreatic masses: high yield of 2 passes with combined histologic-cytologic analysis. Gastrointest Endosc 2009;70:60–69.Article PubMed
64. Tamura T, Yamashita Y, Ueda K, et al. Rapid on-site evaluation by endosonographers during endoscopic ultrasonography-guided fine-needle aspiration for diagnosis of gastrointestinal stromal tumors. Clin Endosc 2017;50:372–378.Article PubMed PMC PDF
65. Cermak TS, Wang B, DeBrito P, Carroll J, Haddad N, Sidawy MK. Does on-site adequacy evaluation reduce the nondiagnostic rate in endoscopic ultrasound-guided fine-needle aspiration of pancreatic lesions? Cancer Cytopathol 2012;120:319–325.Article PubMed

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Outcomes of Endoscopic Ultrasound-guided Fine Needle Biopsy Using a Novel Hydrostatic Stylet Tissue Acquisition Technique
Patrick T. Magahis, Donevan Westerveld, Malorie Simons, David L. Carr-Locke, Kartik Sampath, Reem Z. Sharaiha, SriHari Mahadev
Journal of Clinical Gastroenterology.2024; 58(4): 407. CrossRef
The role of endoscopic ultrasound in assessment of physiological cardia insufficiency during diagnosis of hiatal hernia
B.F. Shevchenko, O.M. Babii, N.V. Prolom, M.V. Titova, S.O. Tarabarov, S.V. Ushchina
GASTROENTEROLOGY.2024; 58(1): 50. CrossRef
Spectrum of endoscopic gastric subepithelial lesions encountered on EUS-FNA: A single center experience
Poojan Agarwal, Pooja Bakshi, Kusum Verma, Vikas Singla, Anil Arora
Indian Journal of Pathology and Microbiology.2024; 67(2): 374. CrossRef
Ultrasound-Enhanced Fine-Needle Biopsy Improves Yield in Human Epithelial and Lymphoid Tissue
Yohann Le Bourlout, Minna Rehell, Jetta Kelppe, Jaana Rautava, Emanuele Perra, Jouni Rantanen, Gösta Ehnholm, Nick Hayward, Kristofer Nyman, Kenneth P.H. Pritzker, Jussi Tarkkanen, Timo Atula, Katri Aro, Heikki J. Nieminen
Ultrasound in Medicine & Biology.2024; 50(8): 1247. CrossRef
Clinical course of asymptomatic duodenal subepithelial lesions
Seokin Kang, Kwangbeom Park, Do Hoon Kim, Yuri Kim, Hee Kyong Na, Jeong Hoon Lee, Ji Yong Ahn, Kee Wook Jung, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung
The Korean Journal of Internal Medicine.2024; 39(4): 603. CrossRef
Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors
Sofia Gabellone, Silvia Vanni, Valentina Fausti, Giacomo Miserocchi, Chiara Liverani, Chiara Spadazzi, Claudia Cocchi, Chiara Calabrese, Davide Cavaliere, Carlo Alberto Pacilio, Giorgio Ercolani, Federica Pieri, Lorena Gurrieri, Nada Riva, Robin Jones, Al
Heliyon.2024; 10(23): e40596. CrossRef
Endoscopic Mucosal Resection of Pancreatic Rest Presenting as a Sub-epithelial Nodule in the Gastric Antrum
Janak Bahirwani, Rodrigo Duarte-Chavez, Lisa Stoll, Ayaz Matin
Cureus.2023;[Epub] CrossRef
Lesiones subepiteliales gástricas únicas. ¿Existen factores predictores de tumores del estroma gastrointestinal que eviten la biopsia?
José Ruiz Pardo, Elisabet Vidaña Márquez, Pedro Antonio Sánchez Fuentes, Iñigo Gorostiaga Altuna, Ricardo Belda Lozano, Ángel Reina Duarte
Gastroenterología y Hepatología.2023; 46(1): 54. CrossRef
Single gastric subepithelial lesions. Are there predictors of gastrointestinal stromal tumors that prevent biopsy?
José Ruiz Pardo, Elisabet Vidaña Márquez, Pedro Antonio Sánchez Fuentes, Iñigo Gorostiaga Altuna, Ricardo Belda Lozano, Ángel Reina Duarte
Gastroenterología y Hepatología (English Edition).2023; 46(1): 54. CrossRef
Endoscopic Submucosal Dissection for Subepithelial Tumor Treatment in the Upper Digestive Tract: A Western, Multicenter Study
Raffaele Manta, Francesco Paolo Zito, Francesco Pugliese, Angelo Caruso, Santi Mangiafico, Alessandra D’Alessandro, Danilo Castellani, Ugo Germani, Massimiliano Mutignani, Rita Luisa Conigliaro, Luca Reggiani Bonetti, Takahisa Matsuda, Vincenzo De Frances
GE - Portuguese Journal of Gastroenterology.2023; 30(2): 115. CrossRef
Endoscopic ultrasonography in diagnosis of digestive diseases. Review of clinical cases
Yu.M. Stepanov, N.V. Prolom, S.O. Tarabarov, M.V. Titova, I.M. Adamska, O.V. Zeleniuk
GASTROENTEROLOGY.2023; 57(4): 234. CrossRef
A Novel Biopsy Method Based on Bipolar Radiofrequency Biopsy Needles
Huiyang Wang, Haiwei Bao, Lan Yue, Tian’an Jiang
Frontiers in Oncology.2022;[Epub] CrossRef
Diagnostic ability of EUS-FNB with a novel fork-tip needle for upper gastrointestinal subepithelial tumors
Kei Ushikubo, Yuto Shimamura, Mai Fukuda, Raina Fujiyoshi, Hiroyuki Watanabe, Yuusuke Fujiyoshi, Jin Tanaka, Yohei Nishikawa, Haruo Ikeda, Manabu Onimaru, Haruhiro Inoue
Progress of Digestive Endoscopy.2022; 100(1): 67. CrossRef
Underwater endoscopic mucosal resection of upper gastrointestinal subepithelial tumors: A case series pilot study (with video)
Su Jin Kim, Tae Un Kim, Cheol Woong Choi, Hyung Wook Kim, Su Bum Park, Dae Gon Ryu
Medicine.2022; 101(41): e31072. CrossRef
AGA Clinical Practice Update on Management of Subepithelial Lesions Encountered During Routine Endoscopy: Expert Review
Kaveh Sharzehi, Amrita Sethi, Thomas Savides
Clinical Gastroenterology and Hepatology.2022; 20(11): 2435. CrossRef
Comparison of diagnostic performances of slow-pull suction and standard suction in endoscopic ultrasound-guided fine needle biopsy for gastrointestinal subepithelial tumors
Joon Seop Lee, Chang Min Cho, Yong Hwan Kwon, An Na Seo, Han Ik Bae, Man-Hoon Han
Clinical Endoscopy.2022; 55(5): 637. CrossRef
The role of endoscopic ultrasound investigation in the diagnosis of submucosal neoplasms of the stomach and duodenum (literature review and our clinical observations)
Yu.M. Stepanov, N.V. Prolom, I.S. Konenko, S.O. Tarabarov, N.P. Dementii, I.M. Adamska
GASTROENTEROLOGY.2022; 55(4): 270. CrossRef
Peroral endoscopic tumor resection (POET) with preserved mucosa technique for management of upper gastrointestinal tract subepithelial tumors
Chen-Shuan Chung, Kuo-Hsin Chen, Kuan-Chih Chen, Chiung-Yu Chen, Tzong-Hsi Lee, Cheng-Kuan Lin, Jiann-Ming Wu
Surgical Endoscopy.2021; 35(7): 3753. CrossRef
Gastric Angiolipoma Resected with Endoscopic Submucosal Dissection
Sang Myung Yeo, Jae Kwang Lee, Hyun Soo Kim, Chang Geun Park, Jae Kwon Jung, Dae Jin Kim, Yun Jin Chung, Han Jun Ryu
Clinical Endoscopy.2021; 54(3): 432. CrossRef
Subepithelial Tumor-like Gastric Cancer
Kyoungwon Jung, Moo In Park
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(2): 106. CrossRef
Convolutional neural network‐based object detection model to identify gastrointestinal stromal tumors in endoscopic ultrasound images
Chang Kyo Oh, Taewan Kim, Yu Kyung Cho, Dae Young Cheung, Bo‐In Lee, Young‐Seok Cho, Jin Il Kim, Myung‐Gyu Choi, Han Hee Lee, Seungchul Lee
Journal of Gastroenterology and Hepatology.2021; 36(12): 3387. CrossRef
Fine needle aspiration cytology of primary and metastatic gastrointestinal stromal tumour
Gargi Kapatia, Nalini Gupta, Uma Nahar Saikia, Parikshaa Gupta, Manish Rohilla, Ojas Gupta, Radhika Srinivasan, Arvind Rajwanshi, Pranab Dey
Cytopathology.2020; 31(2): 136. CrossRef
Thoracoscopic surgery combined with endoscopic creation of a submucosal tunnel for a large complicated esophageal leiomyoma
Koki Oyama, Kenoki Ohuchida, Koji Shindo, Taiki Moriyama, Yoshitaka Hata, Masafumi Wada, Eikichi Ihara, Shuntaro Nagai, Takao Ohtsuka, Masafumi Nakamura
Surgical Case Reports.2020;[Epub] CrossRef
Mucosal Incision-Assisted Endoscopic Biopsy as an Alternative to Endoscopic Ultrasound-Guided Fine-Needle Aspiration/Biopsy for Gastric Subepithelial Tumor
Cheol Woong Choi, Joo Ha Hwang
Clinical Endoscopy.2020; 53(5): 505. CrossRef
Endoscopic diagnosis and management of gastric subepithelial lesions
Thomas R. McCarty, Marvin Ryou
Current Opinion in Gastroenterology.2020; 36(6): 530. CrossRef
Endoscopic submucosal dissection as alternative to surgery for complicated gastric heterotopic pancreas
Jin Hee Noh, Do Hoon Kim, So-Woon Kim, Young Soo Park, Hee Kyong Na, Ji Yong Ahn, Kee Wook Jung, Jeong Hoon Lee, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung
World Journal of Clinical Cases.2020; 8(20): 4708. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy in Gastrointestinal Subepithelial Tumors

Clin Endosc. 2019;52(4):314-320. Published online July 30, 2019

DOI: https://doi.org/10.5946/ce.2019.100

XML Download

Figure

Related articles

Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy in Gastrointestinal Subepithelial Tumors

Fig. 1. Endoscopic ultrasound features suggestive of a malignant gastric subepithelial tumor.

Fig. 1.

Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy in Gastrointestinal Subepithelial Tumors

Malignant features on endoscopy

Large size (≥2 cm)

Ulceration

Irregular surface

Growth during follow-up

Malignant features on EUS

Echogenic foci >3 mm

Cystic spaces >4 mm

Irregular border

Adjacent lymph node

Variable	Study	Location (n)	Results
Needle size	Hoda et al. [25]	Stomach (112)	Diagnostic yield: 22 g = 62% diagnostic, 22% suspicious
	Mekky et al. [26]	Stomach (141)	Diagnostic yield: 22 g = 43% diagnostic, 39% suspicious
	Suzuki et al. [27]	Stomach (47)	Diagnostic yield: 22 g = 74.5%
	Larghi et al. [30]	Stomach (96), esophagus, (13) duodenum (10), rectum (2)	Adequate sample: 19 g = 93.4%
	Eckardt et al. [31]	Stomach (46)	Diagnostic yield: 19 g = 52%
	Watson et al. [32]	Stomach (55), esophagus (7), duodenum (4)	Diagnostic yield: 22 g = 64%, 19 g = 79% (p=0.345)
	Imazu et al. [36]	Stomach (20)	Accuracy: 25 g = 60%, 22 g = 80% (p=not significant)
Needle pass	Hoda et al. [25]	Stomach (70), esophagus (34), duodeum (8)	Diagnostic yield: mean needle pass 5.3 = 83.9%
Needle pass	Kim et al. [39]	Stomach (30), esophagus (4), duodenum (2)	Adequate sample: pass 2 = 80.6%, Pass 3 = 79.4%
ROSE	Tamura et al. [64]	Stomach (25), duodenum (6), rectum (1)	Diagnostic accuracy: rose = 100%, no rose = 80% (p=0.03)

Manufacturer/Model	Needle diameter (G)	Intended sample
Boston Scientific, USA
Expect^TM	25, 22, 19 G^a)	Aspirated cells
Expect^TM 19 Flex	19 G Flex	Aspirated cells
Acquire^TM	25, 22 G	Core biopsy
Cook Medical, Ireland & USA
EchoTip^® Ultra	25, 22, 19 G	Aspirated cells
EchoTip^® ProCore^TM	25, 22, 20, 19 G	Core biopsy
Finemedix, Korea
ClearTip^® (A type)	25, 22, 19 G	Aspirated cells
ClearTip^® (B type)	25, 22, 19 G	Core biopsy
Medi-Globe, Germany
SonoTip^® Pro Control	25, 22, 19 G	Aspirated cells
Olympus, Japan^b)
EZ-shot 3 plus	22, 19 G	Aspirated cells + Core biopsy

Table 1. Features of Gastric Subepithelial Tumor Requiring Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy

EUS, endoscopic ultrasound.

Table 2. Studies on Factors Influencing Result of Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy

ROSE, rapid on-site evaluation.

Table 3. Endoscopic Ultrasound-Guided Fine Needle Aspiration Needles

19 G needle have been used to acquire core biopys samples;

Compatible only with Olympus scopes.